Accolade Statistics
Total Valuation
Compugen has a market cap or net worth of $140.30 million. The enterprise value is $49.40 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Compugen has 93.54 million shares outstanding. The number of shares has increased by 2.57% in one year.
| Current Share Class | 93.54M |
| Shares Outstanding | 93.54M |
| Shares Change (YoY) | +2.57% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 16.89% |
| Float | 91.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.18 |
| Forward PS | n/a |
| PB Ratio | 2.79 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.74 |
| Quick Ratio | 4.74 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.66% and return on invested capital (ROIC) is -21.61%.
| Return on Equity (ROE) | -35.66% |
| Return on Assets (ROA) | -11.43% |
| Return on Invested Capital (ROIC) | -21.61% |
| Return on Capital Employed (ROCE) | -23.05% |
| Revenue Per Employee | $299,243 |
| Profits Per Employee | -$261,676 |
| Employee Count | 74 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Compugen has paid $4.52 million in taxes.
| Income Tax | 4.52M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.98% in the last 52 weeks. The beta is 2.62, so Compugen's price volatility has been higher than the market average.
| Beta (5Y) | 2.62 |
| 52-Week Price Change | -7.98% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 45.59 |
| Average Volume (20 Days) | 257,949 |
Short Selling Information
| Short Interest | 1.37M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 1.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.69 |
Income Statement
In the last 12 months, Compugen had revenue of $22.14 million and -$19.36 million in losses. Loss per share was -$0.21.
| Revenue | 22.14M |
| Gross Profit | 13.80M |
| Operating Income | -19.81M |
| Pretax Income | -509,000 |
| Net Income | -19.36M |
| EBITDA | -19.33M |
| EBIT | -19.81M |
| Loss Per Share | -$0.21 |
Full Income StatementBalance Sheet
The company has $93.88 million in cash and $2.97 million in debt, giving a net cash position of $90.91 million or $0.97 per share.
| Cash & Cash Equivalents | 93.88M |
| Total Debt | 2.97M |
| Net Cash | 90.91M |
| Net Cash Per Share | $0.97 |
| Equity (Book Value) | 50.26M |
| Book Value Per Share | 0.54 |
| Working Capital | 77.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.66 million and capital expenditures -$311,000, giving a free cash flow of -$8.97 million.
| Operating Cash Flow | -8.66M |
| Capital Expenditures | -311,000 |
| Free Cash Flow | -8.97M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 62.33%, with operating and profit margins of -89.46% and -87.45%.
| Gross Margin | 62.33% |
| Operating Margin | -89.46% |
| Pretax Margin | -67.02% |
| Profit Margin | -87.45% |
| EBITDA Margin | -87.28% |
| EBIT Margin | -89.46% |
| FCF Margin | n/a |
Dividends & Yields
Compugen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.57% |
| Shareholder Yield | -2.57% |
| Earnings Yield | -13.80% |
| FCF Yield | -6.40% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 8.85% |
| EPS Growth Forecast (5Y) | 13.08% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Compugen has an Altman Z-Score of -4.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.49 |
| Piotroski F-Score | 2 |
